Company Overview

desc img

A newly created division of Wockhardt USA, Wockhardt USA Injectables is dedicated to providing injectable products that meet the highest standards as required by the United States FDA. With our own dedicated manufacturing facility in Mumbai, India, our highly skilled team of scientists, quality assurance and regulatory experts support all manufacturing and quality requirements of the United States Food and Drug Administration.

Our talented manufacturing team is capable of producing cephalosporin, aqueous, peptide, oncoloytics, and biologics in vials, syringes and Large Volume Parenterals (up to 540ml). In addition, we are capable of leveraging business development partnerships for the introduction of specialty technologies, such as Pen Injector devices for the delivery of patient self-administration products.

Wockhardt USA Injectable's product portfolio is poised to undergo rapid growth in a short period of time, as we plan to recommercialize 5 ANDA products presently in short supply as well as 11 additional ANDA products presently in various stages of development or pending regulatory approval.


The mission of Wockhardt USA Injectables is to provide a consistent and reliable supply of all products within our injectable portfolio, allowing healthcare providers to deliver top notch care resulting in superior patient outcomes.

Value Proposition:

Wockhardt USA Injectables will optimize its manufacturing resources and global supply chain to provide reliable and consistent delivery our entire injectable portfolio of products.